| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035695 |
| Receipt No. | R000040659 |
| Official scientific title of the study | Preventive effects of ramelteon on postoperative delirium after elective liver resection |
| Date of disclosure of the study information | 2019/01/31 |
| Last modified on | 2019/01/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Preventive effects of ramelteon on postoperative delirium after elective liver resection | |
| Title of the study (Brief title) | Preventive effects of ramelteon on postoperative delirium after elective liver resection | |
| Region |
|
|
| Condition | ||
| Condition | postoperative delirium after liver resection | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study was to examine whether ramelteon is effective for the prevention of delirium in elective liver resection. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | incidence of postoperative delirium |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent liver resection at Nara Medical University (Nara, Japan) from January 2014 to August 2018 were retrieved. | |||
| Key exclusion criteria | Patients who could not take water or medicine on POD 1 were excluded. | |||
| Target sample size | 306 | |||
| Research contact person | |
| Name of lead principal investigator | Daisuke Hokuto |
| Organization | Nara Medical University |
| Division name | Department of surgery |
| Address | 840 shijyo-cho, Kashihara city, Nara, Japan |
| TEL | 0744223051 |
| hokuto@naramed-u.ac.jp | |
| Public contact | |
| Name of contact person | Daisuke Hokuto |
| Organization | Nara Medical University |
| Division name | Department of surgery |
| Address | 840 shijyo-cho, Kashihara city, Nara, Japan |
| TEL | 0744223051 |
| Homepage URL | |
| hokuto@naramed-u.ac.jp | |
| Sponsor | |
| Institute | Nara Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nara Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Patients who underwent liver resection at Nara Medical University (Nara, Japan) from January 2014 to August 2018 were retrieved. During the period from January 2017 to August 2018, ramelteon was prospectively administered to patients undergoing liver resection (ramelteon group), whereas ramelteon was not administered during the period from January 2014 to December 2016 (control group). The perioperative outcomes of the ramelteon group and the control group were compared. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040659 |